Intuitive Surgical, Inc.
Intuitive Surgical develops minimally invasive care products. They offer da Vinci surgical systems for complex surgery and Ion endoluminal system for biopsies. Products include stapling, energy, and core instrumentation. The company provides service and support, including installation, repair, and technical support. Products are sold through direct sales teams. Intuitive Surgical has a collaboration agreement with FluoGuide A/S for head & neck cancer treatment.
Overview
Sector
Medical Instruments & Supplies
Strengths
- The company has low debt. Net Debt to EBITDA Ratio is 0.52 and it is lower than the sector mean.
- The company has high returns. ROIC (12.12%) is higher than the sector mean (8.23%).
- Strong EBITDA Margin of 33.66%.
Weaknesses
- With a depreciation Potential of -85.47%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Price to book ratio (10.75) is significantly higher than the sector mean (3.86).
- EV/EBITDA (63.35) is significantly higher than the sector mean (47.53).
- The Price to Free Cash Flow ratio (135.46) is significantly higher than the sector mean.
Key Financial Data
| Indicator | Value |
|---|
| PER | 76.0 |
| EV/EBITDA | 63.4 |
| Price/Free Cash Flow' | 135.5 |
| ROIC | 12.1% |
| Net Debt/EBITDA | 0.5 |